ChemedFRA:CXM +2.54%72 Days Inventory is 1.51 as of Mar. 2026, which is 23% below its 10-year median of 1.95. GuruFocus rates FRA:CXM with a GF Score™ of 72/100 and a GF Value™ of €580.90 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 495 Healthcare Providers & Services companies, Chemed ranks better than 95.96% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Chemed's Average Total Inventories for the
three
months ended in Mar. 2026 was €6 Mil. Chemed's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €382 Mil.
Hence, Chemed's Days Inventory for the
three
months ended in Mar. 2026 was 1.51.
The historical rank and industry rank for Chemed's Days Inventory or its related term are showing as below:
FRA:CXM'
s Days Inventory Range Over the Past 10 Years
Min: 1.64 Med: 1.95 Max: 2.77
Current: 1.7
During the past 13 years, Chemed's highest Days Inventory was 2.77. The lowest was 1.64. And the median was 1.95.
FRA:CXM's Days Inventory is ranked better than 95.96% of 495
companies
in the Healthcare Providers & Services industry
Industry Median: 30.42
vs FRA:CXM: 1.70
Chemed's Days Inventory
declined
from Mar. 2025 (1.72) to Mar. 2026 (1.51).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Chemed's Inventory Turnover for the
three
months ended in Mar. 2026 was 60.28.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Chemed's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.01.
Chemed (FRA:CXM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Chemed's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Chemed's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Chemed Days Inventory Related Terms
Chemed Days Inventory Historical Data
* Premium members only.
The historical data trend for Chemed's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:CXM vs PACS, LFST, CON: Days Inventory Comparison
For the Medical Care Facilities subindustry, Chemed's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chemed Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chemed's Days Inventory distribution charts can be found below:
* The bar in red indicates where Chemed's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chemed (FRA:CXM) has a Days Inventory of 1.51 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Chemed and its competitors. This is 23% below median its historical median of 1.95. Over the past decade, Chemed's Days Inventory has ranged from 1.64 to 2.77. According to the industry distribution chart, Chemed ranks #20 out of 495 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is Chemed's Days Inventory too high?
Chemed's current Days Inventory of 1.51 is 23% below median its 10-year median of 1.95. Over the past 10 years, this metric has ranged from a low of 1.64 to a high of 2.77. The Healthcare Providers & Services industry median Days Inventory is 30.42. Chemed's value of 1.51 is 95% below this industry median. Based on the distribution chart, Chemed ranks #20 out of 495 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Chemed has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chemed's Days Inventory compare to PACS and LFST?
According to the Healthcare Providers & Services industry distribution chart, Chemed ranks #20 out of 495 companies for Days Inventory. This places Chemed in the top 4% of its industry — outperforming the majority of peers. The industry median Days Inventory is 30.42. Chemed's value of 1.51 is 95% below this benchmark. Historically, Chemed's own Days Inventory has ranged from 1.64 to 2.77 over the past decade. While the company's 10-year median is 1.95 vs. the industry median of 30.42, Chemed has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 30.42, based on 495 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemed's current Days Inventory of 1.51 is 95% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Chemed and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 30.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemed's current Days Inventory is 1.51, which is 23% below median its own 10-year median of 1.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemed stock overvalued right now?
Based on GuruFocus' analysis, Chemed (FRA:CXM) is currently considered Significantly Undervalued. The stock's GF Value™ is €580.90, compared to a current price of €404.00 — trading 30.5% below its estimated fair value. The current Days Inventory is 1.51, which is 23% below median its 10-year median of 1.95 and 95% below the Healthcare Providers & Services industry median of 30.42. Chemed's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Chemed (FRA:CXM), the current Days Inventory is 1.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chemed (FRA:CXM) Overvalued in 2026?
Based on GuruFocus' analysis, Chemed stock appears to be undervalued.
The current stock price of €404.00 is trading 30.5% below its estimated GF Value™ of €580.90.
GuruFocus considers Chemed to be Significantly Undervalued.
Key valuation signals for FRA:CXM:
Days Inventory: 1.51 (23% below median its 10-year median of 1.95)
GF Value™: €580.90 vs. price of €404.00 (30.5% below fair value)
Industry Position: 95% below the Healthcare Providers & Services median (#20 of 495)
No single metric tells the full story. See the FRA:CXM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
72GF Score
Get the complete analysis for FRA:CXM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CXM has been successfully added to your 
